It is also noteworthy that FBXL19-AS1 has been reported to be associated with a variety of cancers, and therefore, the need to combine FBXL19-AS1 and AFP to enhance the diagnostic specificity of HCC should be emphasized. Here, FBXL19 is linked to hepatocellular carcinoma.